Waters Corporation (WAT)
| Previous close | 294.23 |
| Open | 296.18 |
| Bid | 0.00 x 1100 |
| Ask | 0.00 x 800 |
| Day's range | 294.12 - 299.76 |
| 52-week range | 231.90 - 363.80 |
| Volume | |
| Avg. volume | 402,387 |
| Market cap | 17.594B |
| Beta (5Y monthly) | 0.96 |
| PE ratio (TTM) | 27.39 |
| EPS (TTM) | 10.83 |
| Earnings date | 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 26 Nov 1996 |
| 1y target est | 326.88 |
Simply Wall St.Is Waters Corporation's (NYSE:WAT) ROE Of 56% Impressive?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
PR NewswireWaters Corporation Schedules First Quarter 2024 Earnings Conference Call
Waters Corporation (NYSE:WAT) will hold its Q1 2024 financial results conference call live on Tuesday, May 7th, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least June 4th, 2024, at midnight Eastern Time.
PR NewswireWaters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors
Analytica 2024 -- Waters Corporation (NYSE:WAT) today announced the launch of the Alliance iS Bio HPLC System with new capabilities that address the operational and analytical challenges of biopharma quality control (QC) laboratories. The new HPLC system combines advanced bio-separation technology and built-in instrument intelligence features. It is designed to help biopharma QC analysts boost efficiency and eliminate up to 40% of common errors, saving time lost by investigating the source of fa
